AbbVie’s Blockbuster Vraylar Adds Significant Indication, Adjunctive MDD

 
• By Joseph Haas
  
FDA approved
Adjunctive MDD is Vraylar's fourth US label indication • Source: Shutterstock

More from New Products

More from Scrip